Objective: The aim of our study was to conduct a meta-analysis of reports published on hepatic resection for colorectal liver metastasis (CRLM) and determine whether a negative margin of 1 cm or more confers a survival advantage over subcentimeter negative margins. Background: Surgical margin is an important prognostic factor in patients undergoing hepatic resection for CRLM. Although there is a consensus that positive margins portend a worse outcome than negative margins, the extent of negative margins remains controversial. Methods: A PubMed search was conducted to identify articles on hepatic resection for CRLM. The 357 initially located articles were screened to identify 90 articles of interest. The texts of these 90 articles were completely reviewed to finalize 18 articles for inclusion in the study on the basis of absolute and relative inclusion criteria. Patients with positive margins were excluded from the meta-analysis. Meta-analysis was performed using STATA 9.2 statistical software. Results: A total of 4821 patients with negative margins from the 18 studies were included in the meta-analysis. The overall 5-year survival for all patients was 41% [95% confidence interval (CI), 40%-43%]. The overall 5-year survival for the ≥1 cm negative margin subgroup was 46% (95% CI, 44%-48%) when compared with 38% (95% CI, 36%-40%) for less than 1 cm negative margin subgroup. The odds ratio for 1-cm or more negative margins was found to be 0.773 (95% CI, 0.638-0.938; P = 0.009) when compared with less than 1 cm negative margins.
C olorectal cancer (CRC) is the fourth most common malignancy with approximately 146,970 new cases diagnosed in 2009
1 and is the second most common cause of cancer-related deaths accounting for approximately 49,920 deaths in 2009. 1 Metastases remain the major cause of mortality in patients with CRC with liver being the only site of metastases in approximately 30% of the patients. 2 Hepatic resection remains a well-accepted modality in the treatment of patients with colorectal liver metastases (CRLM) with 5-year survival rate ranging from 37% to 58%. [3] [4] [5] [6] Fong et al 4 and Nordlinger et al 7 have delineated several clinicopathologic factors including primary tumor stage, disease free interval of less than 12 months, preoperative carcinoembryonic antigen levels, number and size of metastatic tumors, presence of extrahepatic disease, etc to be independent predictors of overall survival after hepatic resection.
Surgical resection margin is also considered to be an additional prognostic factor. Although there is a consensus that positive margins portend a worse outcome as compared with negative margins, the extent of negative margins remains controversial. Several studies have documented a survival advantage of 1 cm or more negative margins over less than 1 cm negative margins of resection, 3, 7, 8 whereas others have concluded that the width of negative margin has no influence on outcome. 5, 6, 9 The aim of the current study was to perform a meta-analysis of studies published on CRLM (using surgical resection as a primary mode of treatment) to determine whether negative resection margins of 1 cm or more confer any survival advantage over negative resection margins of less than 1 cm.
MATERIALS AND METHODS Search Strategy and Inclusion/Exclusion Criteria
Articles in PubMed database from 1966 to the present were searched using the key words (1) "Colorectal metastases" and ("Liver resection" or "Hepatic resection") (2) Search 1 and "margins." The search was restricted to articles published in English language. We identified 357 articles with some overlap between the 2 categories. A backward search was also performed using cross-references from the bibliographies of relevant articles and review articles to ensure a comprehensive search. Figure 1 depicts the search strategy in detail.
The following articles were excluded from the analysis:
1. Review articles/letters. 2. Articles analyzing patients with recurrent hepatic metastases only. 3. Articles including patients with noncolorectal hepatic metastases. 4. Articles including patients mainly treated with ablation therapies such as cryotherapy, radiofrequency ablation, or chemoembolization. 5. Articles comparing patients who underwent resection with patients who underwent no treatment or nonresectional treatment.
To select relevant and high-quality articles, we further substratified our inclusion criteria into absolute and relative inclusion criteria.
Absolute criteria for inclusion were as follows:
1. Inclusion of margin of resection as a variable in outcome analysis. 2. Calculation of percentage 5-year survival with margin of resection as a variable. 3. Subcategorization of negative margins into subcentimeter (with or without additional subgroups) and more than a centimeter subgroups.
FIGURE 1. Study flow diagram.
Studies should meet at least 70% (5 of 7) of the relative criteria that were defined as follows:
1. Clear statement of study hypothesis. 2. Clear statement of the main outcome of the study. 3. Description of the demographic characteristics of the study population. 4. Description of operative mortality. 5. Description of length of follow-up. 6. Description of percentage of patients who were lost to follow-up.
Full texts were reviewed for 90 articles. Duplicate publications by the authors on the same data set, that is, patients operated during the same duration, were excluded. [10] [11] [12] [13] In such cases, the most recent publication of the authors was included in the analysis. [14] [15] [16] [17] Although common authors were identified in the studies by Are et al 3 and Fong et al, 18 both were included in the meta-analysis as the patient samples were derived from different time periods.
Data Extraction and Definitions
Estimates of 5-year overall survival and the number of patients (including patients in each margin subcategory) were extracted from the studies (texts or tables). In the study by Elias et al, 20 the 5-year survival for "≥ 1 cm" category was computed from the Kaplan-Meier graph as it was not mentioned in the text or tables. However, if the results for all margin subcategories were reported only as Kaplan-Meier graph, the studies were excluded. 28 Patients with positive margins were excluded from the current meta-analysis and only patients with negative margins were included. Many studies substratified subcentimeter negative margins into different subcategories. 3, 6, 15, 19, 24, 25 For these studies, a weighted mean was calculated using the number of patients in each subcategory and the corresponding percentage survival, to compute percentage survival for the whole <1 cm negative margin subgroup. Some studies 3, 5, 14, 18, 21, 26 categorized negative margins as "≤1 cm and >1 cm," whereas others 6, 8, 9, [15] [16] [17] 19, 20, [23] [24] [25] 27 used "<1 cm and ≥1 cm" for negative margins. Hughes et al 22 used "<1 cm and >1 cm" subcategories for negative margins in their study. For the purpose of meta-analysis, ≤1 cm and <1 cm were treated as "<1 cm" and > 1 cm and ≥1 cm were treated as "≥1 cm." This had to be done because of lack of individual patient data. This will lead to misclassification of some patients with exactly 1-cm margins into "<1 cm subcategory" and will bias our meta-analysis toward good outcome in <1 cm margins. However, it seemed to be the more conservative approach. At the same time, it will increase the power and precision of our meta-analysis by allowing us to include more studies. Meta-analysis was performed using the number of patients who were dead or alive at 5 years in the "<1 cm" and "≥ 1 cm" subgroups. Subgroup analysis was performed for 11 studies with similar Copyright © 2011 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
subgroups for negative margins as used in the current meta-analysis, that is, "<1 cm and ≥ 1 cm." Subgroup analysis was also performed for the 7 largest studies included in the meta-analysis with a sample size of more than 200 each.
Statistical Methods
Meta-analysis was performed using STATA 9.2 statistical software (StataCorp, College Station, TX). All data were treated as binary (dead vs alive at 5 years, <1 cm vs ≥1 cm). An estimate of the number of patients who survived 5 years was calculated by multiplying the total number of patients in <1 cm and ≥ 1 cm subcategories included in the study by the corresponding 5-year survival estimate. Odds ratios and 95% CIs computed from the binary data were used for the final meta-analysis. Random effects model was used because of our suspicion of heterogeneity among different studies. Heterogeneity was explored using the χ 2 test with a significance level of P = 0.10. I 2 was calculated to further quantify heterogeneity. Publication bias was explored using funnel plots and symmetry of the funnel plot was analyzed using objective tests such as Egger and Begg tests. Sensitivity analysis was performed to measure the effect of the 7 largest studies and to rule out any effects or bias from the studies with small patient samples.
RESULTS
After application of the absolute inclusion criteria, relative inclusion criteria, and removal of duplicate publications, 18 studies 3,5,6,8,9,14-27 qualified for inclusion in the meta-analysis. Table 1 summarizesthe study characteristics of the final 18 studies included in the meta-analysis. The majority of studies were retrospective except for the report by Elias et al. 20 and consisted of 4821 patients. The total number of patients in the included studies varied from 314 to 1019. The mean or median age for most of the studies was in 50s or 60s with the majority reporting a mean or median follow-up period of at least 2 years. Table 2 summarizes the number of patients with data on margins and estimates of 5-year survival in each individual study. The sample size of the studies varied from 80 patients to 907 patients (i.e., patients on whom data on margins were available). Estimates of 5-year survival ranged from 20% to 66% for the <1 cm negative margins subgroup and 23% to 63% for the ≥1 cm subgroup. The overall 5-year survival for all patients was 41% [95% CI, 40%-43%]. The overall 5-year survival for the ≥1 cm negative margin subgroup was 46% (95% CI, 44%-48%) when compared with 38% in the <1 cm negative margin subgroup (95% CI, 36%-40%).
The odds ratio for the ≥1 cm negative margins was found to be 0.773 (95% CI, 0.638-0.938; P = 0.009) when compared with <1 cm negative margins (referent). A statistically significant improvement in 5-year survival was seen in patients with negative margins ≥1 cm relative to patients with <1 cm negative margins. There was statistically significant heterogeneity among the studies (P = 0.005) and the contribution of heterogeneity to variation in odds ratio was as high as 52%. Figure 2 summarizes the results of the meta-analysis.
We also performed a separate analysis of 11 studies, 6, 8, 9, [15] [16] [17] 20, [23] [24] [25] 27 which used similar subclassification <1 cm (with or without additional subgroups) and ≥1 cm for negative margins as used in our meta-analysis. The odds ratio for ≥1 cm was found to be 0.734 (95% CI, 0.549-0.983; P = 0.038). Again, a statistically significant improvement in 5-year survival was seen in patients with a negative margin of ≥1 cm relative to patients with <1 cm negative margins. There was statistically significant heterogeneity among the studies (P = 0.004) and the contribution of heterogeneity to variation in odds ratio was as high as 61.2%. Figure 3 summarizes the results of the meta-analysis in this subset of 11 studies. Similar results were obtained when analysis was restricted to the 7 largest studies ( Figure 4 ) with a sample size of more than 200 patients in each study 3, 5, 6, 14, 17, 18, 23 (odds ratio = 0.795; 95% CI, 0.663-0.954; P = 0.013). These 7 studies showed no significant heterogeneity (P = 0.207) and contribution of heterogeneity to variation in odds ratio was only 28.9%.
PUBLICATION BIAS
Publication bias was explored using funnel plots ( Figure 5 ). Multiple tests were performed to rule out asymmetry of funnel plot including Egger (bias coefficient 0.109, standard error 0.983, t = 0.11, P = 0.913) and Begg (z = 0.23, P = 0.820). In addition, a meta-analysis that included the 7 largest studies 3, 5, 6, 14, 17, 18, 20, 21, 23, 27 revealed an odds ratio of 0.795 (95% CI, 0.663-0.954; P = 0.013), suggesting that the contribution of other small studies to bias the results is minimal (0.022 or 2.2% derived from difference in odds ratios 0.795-0.773 = 0.022). These tests suggest that chances of publication bias are minimal.
DISCUSSION
Hepatic resection is the only treatment modality known to offer the hope of prolonged survival in patients with CRLM. 29, 30 Several studies have documented the influence of various variables on survival after hepatic resection for CRLM. 4, 7 Some of these variables are primary tumor stage, disease free interval of less than 12 months, preoperative carcinoembryonic antigen levels, number and size of metastatic tumors, presence of extrahepatic disease, etc. 4, 7 The surgical resection margin is, to some extent, one of the few variables under the direct influence of the operative technique and has been shown to have a bearing on the outcomes after hepatic resection for CRLM. 2, 3, [5] [6] [7] [8] 14, [16] [17] [18] [20] [21] [22] [23] [24] [25] [26] [27] There is a general consensus that patients with positive margins have a worse outcome when compared with patients with negative margins. 2, 3, 6, 8, 14, 21, 25 Although patients with negative margins have a better outcome, controversy exists as to what this width should be.
The early studies documented a survival advantage of margin width of >1 cm. 28, 31 In contrast, other reports have concluded that width of margins is not important as long as the margins are negative. 5, 6, 27 The majority of studies on the topic are retrospective and very heterogeneous in methodology and end point assessment. In addition, there is a wide variation in how the width of negative margins is defined and assessed. Although a well-conducted prospective randomized controlled trial would address the issue, such a trial might not be feasible and may be unethical. Given these limitations, we attempted to address the influence of negative margin width on survival by combining the most relevant studies in the form of a metaanalysis. A meta-analysis combines the results of several studies and yields a quantitative summary of the pooled results. 32 The benefits of meta-analysis include the ability to improve the power of inconclusive studies and identify sources of diversity or heterogeneity across various types of studies. This would be appropriate for assessing the influence of margins as there is so much heterogeneity in the studies published.
The overall survival for the entire cohort of included patients was 41%, which is in concurrence with most of the published individual studies. 3, 5, 18, 24, 27 The results of our study demonstrated a survival advantage for patients with ≥ 1 cm negative margins when compared with <1 cm negative margins (46% vs 38%; OR = 0.773; 95% CI, 0.638-0.938; P = 0.009). Although it seems intuitive that a wider margin is beneficial for all oncologic operations, the potential definitive reasons for the survival benefit of ≥1 cm margins for hepatic resection are controversial and beyond the purview of this study. It is likely that all metastatic lesions have circumferential presence of microscopic disease that may be removed by using a wider margin. Wakai et al. have previously demonstrated that intrahepatic lymphatic spread can lead to micro metastasis and most of these are located within a 1 cm region around the metastasis. A resection margin of 1 cm will essentially remove 95% of these micrometastases. Our study has several advantages. It demonstrates a consistent survival advantage of ≥1 cm margin in different types of analyses. Despite wide variance in the definition of margin width in all the 18 included studies, the initial analysis of all reports demonstrated a benefit for ≥1 cm margin. A subset analysis of 11 studies that had similar subclassification of the <1 cm and ≥1 cm negative margins was performed and we noted a similar survival advantage. The final analysis of the 7 largest studies (>200 patients) also demonstrated the similar survival advantage. The uniformity of this survival benefit across the spectrum of analyses demonstrates the validity and robustness of the meta-analysis. Although there are several multi-institutional reports published, the number of patients included in our study (4814) is one of the largest to date. All these patients had negative margins and patients with positive margins were excluded from the current study. We also noted that there was homogeneity in the age distribution of the patients included in the study (Table 1 , mean and median in 50s and 60s). In addition, publication bias is one of the major drawbacks of any meta-analysis. The funnel plots demonstrate an equal distribution of all kinds of studies, thereby ruling out publication bias that can affect the quality of the meta-analysis.
An ideal meta-analysis should be performed using individual patient data; however, individual patient data may not always be available or practical. Therefore, the majority of meta-analyses, including our study, are performed using summary data, which is a well-accepted form of analysis. The next best option will be performance of meta-analysis using hazard ratios. Although 9 studies had hazard ratios available for the various subgroups of margins, different studies controlled for different factors in their multivariate analysis making hazard ratios incomparable. The odds ratio method, although not as accurate as individual patient data and hazard ratios, was found to be the most feasible approach and was therefore used in the current study. This approach has also been used previously in other studies. 33, 34 However, because of the limitation of odds ratio approach, we were not able to control for other factors such as the number of metastases and size of metastases in our meta-analysis. Similarly, the lack of individual patient data limited our ability to analyze the causes of death in the included studies.
There are several limitations to the current meta-analysis. One of the largest studies (N = 1568) showing a positive impact of margins of resection on survival by Nordlinger et al 7 reported only relative risks, which could not be substituted for odds ratios and this study could not be included in the meta-analysis. The techniques utilized to perform parenchymal transaction were variable in different studies (eg, Kelly clamp crush technique, cavitron ultrasonic surgical aspirator). The assessment of margin status can be different for each method of parenchymal transaction and this needs to be kept in mind when interpreting our results. Chemotherapy for metastastic CRC has evolved significantly over the last 2 decades with significant improvements in survival. The studies included in the meta-analysis extend over this period of time and the influence of margins in the era of modern chemotherapy, combined with advanced resection techniques, is not well understood. Although meta-analysis is superior to individual studies or systematic reviews, its quantitative results need to be viewed carefully even when the analysis is performed according to rigorous criteria. Meta-analysis is a statistical examination of the scientific studies included and is not actually a scientific study in itself. The results of the meta-analysis are as good as the studies included. Although the source of the bias can be controlled by testing with funnel plots, a good meta-analysis of badly designed studies will still lead to poor results. We tried to avoid this as much as possible in our study by initially performing an extensive literature search after which we established strict absolute and relative criteria to maintain quality of reports to be included. This enabled us to include the most valid studies currently published from established centers of excellence. In the absence of any randomized controlled trials now or in the future, this meta-analysis may represent a comprehensive analysis of the impact of margins after hepatic resection for CRLM.
In conclusion, the results of our meta-analysis demonstrate a survival benefit for ≥ 1 cm negative margins when compared with <1 cm negative margins for patients undergoing hepatic resection for CRLM. However, because subcentimeter margins are still associated with favorable 5-year survival rates, the inability to obtain 1-cm negative margin should not be a contraindication to hepatic resection. The results of our study need to be interpreted in the backdrop of the subjective design of meta-analysis with its inherent advantages and disadvantages. Because randomized controlled trials on this subject may not be feasible, this meta-analysis may represent a comprehensive analysis of the influence of margins after hepatic resection for CRLM.
